Most Americans don’t have a will. They will work to build a life and home for themselves and take care of their friends and family along the way. Unfortunately at the end of their lives, without a will, their property is up to state law instead of being distributed to their friends, family, or charity organizations of their choosing. Shouldn’t it be up to you to decide where your property goes?
About 1 million knee arthroscopies are performed each year in the United States, at a cost of more than $3 billion. Now, in new guidelines, an international panel of experts has strongly recommended against the surgery for nearly everyone with “degenerative knee disease.” Degenerative knee disease is another way to refer to knee osteoarthritis (OA), and includes degenerative meniscus tears, trouble with knee movement and sudden onset of pain and swelling. The guidelines were published in the journal BMJ in May.
Trillions of bacteria live in or on your body. There are actually as many bacteria in your body as cells in your body. Fortunately, for most of us, most bacteria that live within us are helpful, not harmful. We call these bacteria commensal bacteria. Dr. Martin Kriegel and his team have been studying these bacteria, and more specifically, a protein that humans and bacteria produce, called Ro60, that plays a role in the development of lupus.
Early in life while mowing lawns, growing and selling tomatoes and managing a neighborhood McDonald’s restaurant as a junior in high school, Kevin Mandrell always knew he had a natural knack for business. He was surrounded by strong business leaders and felt drawn from an early age to dive into business on his own.
Continue reading Creating a Legacy to Conquer Arthritis
Often you hear the phrase, “Charity begins at home.” The story of this family can be characterized by the phrase, “Charity begins and ends at home.” Wayne was only in his 20s and attending college in Arizona when he was diagnosed with arthritis. “I remember him saying his back hurt so bad that when he had to cough or sneeze, he found a convenient tree or wall to brace up against it,” says his wife Carole, a retired high school English teacher.
Years later, Carole and Wayne were browsing through a copy of Arthritis Today magazine when an advertisement caught their attention. The ad featured an opportunity to receive guaranteed payout rates for life and other financial benefits – while they helped the Foundation find a cure for arthritis.
Continue reading Charitable Gift Annuity: A Win-Win
Have you ever received information from the Arthritis Foundation’s Planned Giving Department and wondered exactly what it means? Have you ever seen a request to remember the Arthritis Foundation in your will or trust or read that 25% of all revenue the Foundation receives is from donor bequests? Have you ever met one of the Foundation’s Planned Giving Directors and wondered if they could help you? If so, you’re not alone.
Continue reading Planned Giving: Do More with Thoughtful Planning
The American College of Rheumatology’s (ACR) Annual Meeting, which just wrapped up in Washington, D.C., saw record attendance, with about 17,000 attendees from around the world, upward of 3,000 abstracts and more than 250 scientific sessions. It is not possible to capture everything that happened in one blog post, but we do want to share some of the interesting highlights we saw and heard there.
Continue reading Key Highlights and Takeaways from the 2016 ACR Annual Meeting
Along the sandy shores of Ventura, California, over 200 riders made their way along the coast to the last overnight stop of the Arthritis Foundation’s 2016 California Coast Classic Bike Tour. Many stopped for water, snacks and samplings from a local winery and brewery that set up a fantastic happy hour as they wound down from a long day of riding. Approximately 475 miles in, cyclists and volunteers alike wore a smile on their face, excited for one last night before crossing the finish line on Saturday, October 1, 2016.
Continue reading 2016 California Coast Classic Bike Tour Raises Over $1 Million for Arthritis Foundation
The Food and Drug Administration (FDA) has approved etanercept-szzs (brand name: Erelzi), a biosimilar form of etanercept (Enbrel), to treat rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis as well as plaque psoriasis. Earlier this year, infliximab-dyyb (Inflectra), a biosimilar version of infliximab (Remicade), became the first FDA-approved biosimilar for inflammatory types of arthritis in the U.S.
Continue reading FDA Approves Second Arthritis Biosimilar – Biosimilar Version of Drug Enbrel
Help us champion the fight against arthritis with planned giving! In our past posts in the Planned Giving Series, we discussed the type of planned gifts we accept and an overview of planned giving to help you better understand how planned gifts differ from other types of donations to the Arthritis Foundation.
In our last post about how to give (part one), we talked about several types of gift models we accept that have multiple benefits for you and your loved ones, including bequests, beneficiary designation gifts, charitable gift annuities and more. Below, we’ll discuss additional alternate types of planned gifts you can make, which will help make a difference in the lives of those with arthritis for years to come!